Brandon Haigh WuXi Advanced Therapies

Brandon J. Haigh is an Associate Director of Cell Therapy Process Development at WuXi Advanced Therapies. With more than 12 years in the biotech industry, Brandon has worked in roles with increasing responsibilities within the CDMO space, encompassing cGMP cell and gene therapy manufacturing, MSAT, process development, technology transfer operations, team development, and scale up/out operations. Simultaneously leveraging past experience with a constantly evolving cGMP landscape, Brandon has led efforts for more than 50 cell banking programs and 20 cell and gene-mediated therapies. Brandon continues to help CDMO-partnered clients navigate industry requirements, strategies, risks, and opportunities through robust collaboration and development as they work to transfer their technology from benchtop through clinical and later-stage manufacturing